Publication bias: what is it? How do we measure it? How do we avoid it?

IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
F. Song, L. Hooper, Y. Loke
{"title":"Publication bias: what is it? How do we measure it? How do we avoid it?","authors":"F. Song, L. Hooper, Y. Loke","doi":"10.2147/OAJCT.S34419","DOIUrl":null,"url":null,"abstract":"Publication bias occurs when results of published studies are systematically different from results of unpublished studies. The term \"dissemination bias\" has also been recommended to describe all forms of biases in the research-dissemination process, including outcome-reporting bias, time-lag bias, gray-literature bias, full-publication bias, language bias, citation bias, and media-attention bias. We can measure publication bias by comparing the results of published and unpublished studies addressing the same question. Following up cohorts of studies from inception and comparing publication levels in studies with statistically significant or \"positive\" results suggested greater odds of formal publication in those with such results, compared to those without. Within reviews, funnel plots and related statistical methods can be used to indicate presence or absence of publication bias, although these can be unreliable in many circumstances. Methods of avoiding publication bias, by identifying and including unpublished outcomes and unpublished studies, are discussed and evaluated. These include searching without limiting by outcome, searching prospective trials registers, searching informal sources, including meeting abstracts and PhD theses, searching regulatory body websites, contacting authors of included studies, and contacting pharmaceutical or medical device companies for further studies. Adding unpublished studies often alters effect sizes, but may not always eliminate publication bias. The compulsory registration of all clinical trials at inception is an important move forward, but it can be difficult for reviewers to access data from unpublished studies located this way. Publication bias may be reduced by journals by publishing high-quality studies regardless of novelty or unexciting results, and by publishing protocols or full-study data sets. No single step can be relied upon to fully overcome the complex actions involved in publication bias, and a multipronged approach is required by researchers, patients, journal editors, peer reviewers, research sponsors, research ethics committees, and regulatory and legislation authorities.","PeriodicalId":19500,"journal":{"name":"Open Access Journal of Clinical Trials","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2013-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/OAJCT.S34419","citationCount":"182","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OAJCT.S34419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 182

Abstract

Publication bias occurs when results of published studies are systematically different from results of unpublished studies. The term "dissemination bias" has also been recommended to describe all forms of biases in the research-dissemination process, including outcome-reporting bias, time-lag bias, gray-literature bias, full-publication bias, language bias, citation bias, and media-attention bias. We can measure publication bias by comparing the results of published and unpublished studies addressing the same question. Following up cohorts of studies from inception and comparing publication levels in studies with statistically significant or "positive" results suggested greater odds of formal publication in those with such results, compared to those without. Within reviews, funnel plots and related statistical methods can be used to indicate presence or absence of publication bias, although these can be unreliable in many circumstances. Methods of avoiding publication bias, by identifying and including unpublished outcomes and unpublished studies, are discussed and evaluated. These include searching without limiting by outcome, searching prospective trials registers, searching informal sources, including meeting abstracts and PhD theses, searching regulatory body websites, contacting authors of included studies, and contacting pharmaceutical or medical device companies for further studies. Adding unpublished studies often alters effect sizes, but may not always eliminate publication bias. The compulsory registration of all clinical trials at inception is an important move forward, but it can be difficult for reviewers to access data from unpublished studies located this way. Publication bias may be reduced by journals by publishing high-quality studies regardless of novelty or unexciting results, and by publishing protocols or full-study data sets. No single step can be relied upon to fully overcome the complex actions involved in publication bias, and a multipronged approach is required by researchers, patients, journal editors, peer reviewers, research sponsors, research ethics committees, and regulatory and legislation authorities.
发表偏倚:是什么?我们如何测量它?我们如何避免它呢?
发表偏倚是指已发表的研究结果与未发表的研究结果存在系统性差异。“传播偏倚”一词也被推荐用来描述研究传播过程中所有形式的偏倚,包括结果报告偏倚、时滞偏倚、灰色文献偏倚、完整发表偏倚、语言偏倚、引用偏倚和媒体注意偏倚。我们可以通过比较针对同一问题的已发表和未发表研究的结果来衡量发表偏倚。从一开始就跟踪研究队列,并比较具有统计学意义或“积极”结果的研究的发表水平,结果表明,与没有结果的研究相比,有这些结果的研究正式发表的几率更大。在综述中,漏斗图和相关的统计方法可用于指示是否存在发表偏倚,尽管在许多情况下这些方法可能不可靠。通过识别和纳入未发表的结果和未发表的研究,讨论和评估避免发表偏倚的方法。这些搜索包括不受结果限制的搜索,搜索前瞻性试验注册,搜索非正式来源,包括会议摘要和博士论文,搜索监管机构网站,联系纳入研究的作者,以及联系制药或医疗器械公司进行进一步研究。添加未发表的研究通常会改变效应大小,但不一定能消除发表偏倚。所有临床试验在一开始就强制注册是一个重要的进步,但审稿人很难通过这种方式获取未发表研究的数据。发表偏倚可以通过发表高质量的研究而不考虑新颖或不令人兴奋的结果,以及发表协议或完整的研究数据集来减少。没有一个单一的步骤可以完全克服发表偏倚所涉及的复杂行动,研究人员、患者、期刊编辑、同行评审、研究发起人、研究伦理委员会以及监管和立法当局需要采取多管齐下的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Open Access Journal of Clinical Trials
Open Access Journal of Clinical Trials MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
3.90
自引率
0.00%
发文量
2
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信